Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic.


Journal

Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362

Informations de publication

Date de publication:
2020
Historique:
pubmed: 18 8 2020
medline: 20 11 2020
entrez: 18 8 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has upended daily life and neurologic care for most patients, including those with Parkinson's disease and parkinsonism. Disruptions to routine care, high volumes of patient and caregiver calls, and our patients' risk of infection and complications inspired a proactive COVID-19 outreach program. This program targets patients with advanced Parkinson's disease and related disorders, specifically those who are homebound, receiving or eligible for palliative care, and/or lacking support networks. We describe the program and practical strategies providers can implement to support wellbeing and successful telehealth uptake during this time of social isolation and gradual reopening.

Identifiants

pubmed: 32804103
pii: JPD202156
doi: 10.3233/JPD-202156
pmc: PMC7606485
mid: NIHMS1638662
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1383-1388

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS097615
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

BMC Neurol. 2017 Jul 1;17(1):126
pubmed: 28666413
Mov Disord. 2020 Jul;35(7):1097-1099
pubmed: 32428342
J Am Med Inform Assoc. 2020 Jun 1;27(6):957-962
pubmed: 32311034
Biomed Res Int. 2017;2017:7962826
pubmed: 29333454
JAMA Intern Med. 2015 Jul;175(7):1180-6
pubmed: 26010119
Eur J Phys Rehabil Med. 2020 Jun;56(3):354-360
pubmed: 32408729
J Telemed Telecare. 2020 Jan-Feb;26(1-2):53-63
pubmed: 30134777
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Ann Palliat Med. 2020 Feb;9(Suppl 1):S80-S89
pubmed: 31735037
Neurol Clin Pract. 2020 Aug;10(4):277-286
pubmed: 32983607
Parkinsonism Relat Disord. 2019 Jul;64:106-111
pubmed: 30930058
J Neurol Sci. 2017 Feb 15;373:210-215
pubmed: 28131190
Geriatr Nurs. 2015 May-Jun;36(3):207-11
pubmed: 25744558
Parkinsons Dis. 2020 Apr 9;2020:7370810
pubmed: 32351682
BMC Geriatr. 2016 Dec 7;16(1):209
pubmed: 27923343
Mov Disord. 2020 Jun;35(6):905-908
pubmed: 32347572
Parkinsonism Relat Disord. 2013 Nov;19(11):949-54
pubmed: 23835430
J Parkinsons Dis. 2017;7(1):193-202
pubmed: 27858719
Cochrane Database Syst Rev. 2015 Apr 09;(4):CD010508
pubmed: 25854331
J Telemed Telecare. 2017 Sep;23(8):740-746
pubmed: 27624469
NPJ Parkinsons Dis. 2019 Jan 24;5:1
pubmed: 30701188
Psychiatr Serv. 2006 Apr;57(4):567-9
pubmed: 16603756
J Parkinsons Dis. 2020;10(2):351-354
pubmed: 32250324
Front Neurol. 2018 Mar 06;9:120
pubmed: 29559949
Parkinsonism Relat Disord. 2014 Nov;20(11):1221-5
pubmed: 25258329
J Med Internet Res. 2018 Oct 26;20(10):e10867
pubmed: 30368437
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Eur J Phys Rehabil Med. 2020 Aug;56(4):508-514
pubmed: 32539312
Mov Disord Clin Pract. 2016 May-Jun;3(3):250-256
pubmed: 27331078
BMJ Glob Health. 2020 May;5(5):
pubmed: 32376777
J Telemed Telecare. 2020 Jun;26(5):309-313
pubmed: 32196391
Clin Interv Aging. 2019 Jul 31;14:1371-1377
pubmed: 31534322
Mov Disord. 2006 Apr;21(4):446-55
pubmed: 16161155
J Health Serv Res Policy. 2008 Jul;13(3):178-84
pubmed: 18573768
Eur J Phys Rehabil Med. 2020 Jun;56(3):347-353
pubmed: 32316718
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Mov Disord. 2020 May;35(5):711-715
pubmed: 32250460

Auteurs

Brianna Sennott (B)

Rush Medical College, Rush University Medical Center, Chicago, IL, USA.

Katheryn Woo (K)

Rush Medical College, Rush University Medical Center, Chicago, IL, USA.

Serena Hess (S)

Section of Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

Daniela Mitchem (D)

Section of Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

Ellen C Klostermann (EC)

Section of Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

Erica Myrick (E)

Section of Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

Sharlet Anderson (S)

Section of Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

Rodolfo Savica (R)

Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.

Jori E Fleisher (JE)

Section of Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH